UPDATE: Goldman Sachs Downgrades Intuitive Surgical on Disappointing 2Q2013 Results
In a report published on Tuesday, Goldman Sachs analyst David H. Roman downgraded Intuitive Surgical (NASDAQ: IRSG) to Neutral and lowered the price target to $500 from $676.
In the report, Goldman Sachs noted, "While procedure volumes were somewhat better than most had feared (no material change in growth vs. Q1), the US capital equipment business looks to be facing material incremental headwinds".
Intuitive Surgical closed on Monday at $500.08.
Latest Ratings for ISRG
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 2022 | UBS | Upgrades | Neutral | Buy |
| Jan 2022 | Piper Sandler | Upgrades | Neutral | Overweight |
| Jan 2022 | Redburn Partners | Downgrades | Buy | Neutral |
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: David H. Roman Goldman SachsAnalyst Color Downgrades Analyst Ratings
